LIFECORE BIOMEDICAL INC DE

For the period ended May 26, 2024. Filed Aug 26, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Aug 26, 2024

LFCR$6.37+0.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item No.	Description	Page
	Cautionary Note About Forward-Looking Statements	2
Part I
1.	Business	2
1A.	Risk Factors	5
1B.	Unresolved Staff Comments	20
1C.	Cybersecurity	20
2.	Properties	22
3.	Legal Proceedings	22
4.	Mine Safety Disclosures	22
Part II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	23
6.	[Reserved]	24
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
7A.	Quantitative and Qualitative Disclosures About Market Risk	37
8.	Financial Statements and Supplementary Data	37
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	37
9A.	Controls and Procedures	37
9B.	Other Information	40
9C.	Disclosure Regarding Jurisdictions that Prevent Inspections	40
Part III
10.	Directors, Executive Officers and Corporate Governance	41
11.	Executive Compensation	41
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	41
13.	Certain Relationships and Related Transactions, and Director Independence	41
14.	Principal Accountant Fees and Services	41
Part IV
15.	Exhibits and Financial Statement Schedules	42
	Signatures	92

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Tableof Contents